Family Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Family Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100,000	Closed	-$1.24M	–	80
2016 Q4	$1.24M	Sell	100,000 -250	-0.2%	-$3.01K	0.85%	33
2016 Q3	$1.37M	Sell	100,250 -79,265	-44%	-$796K	0.78%	39
2016 Q2	$1.33M	Buy	179,515 +1,250	+0.7%	+$9.38K	0.75%	37
2016 Q1	$1.14M	Buy	178,265 +14,750	+9%	+$82.7K	0.74%	29
2015 Q4	$1.02M	Sell	163,515 -259,250	-61%	-$1.7M	0.53%	43
2015 Q3	$2.47M	Buy	422,765 +10,000	+2%	+$77K	1.09%	29
2015 Q2	$3.41M	Buy	412,765 +251,850	+157%	+$2.23M	1.41%	28
2015 Q1	$1.33M	Buy	160,915 +86,000	+115%	+$636K	0.61%	45
2014 Q4	$515K	Buy	+74,915	New	+$469K	0.23%	59

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Family Management's ARIA Position: Q1 2017 in Review

Family Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 100,000 shares — an estimated $1.24M sold.

Family Management first reported a position in ARIA in Q4 2014 and held it in 9 quarters. The position peaked at $3.41M in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Family Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Family Management sold 100,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.24M.
Family Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 9 quarters.
Family Management's Ariad Pharmaceuticals Inc position peaked at $3.41M in Q2 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Family Management's 13F filing for Q1 2017, filed 15 May 2017.